Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 12:27 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 73–96 of 396 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Foot Ulcers, Diabetic Clear all

Conditions: Diabetic Foot Ulcer (DFU), Venous Leg Ulcers (VLUs), Pressure Ulcers, Bedsores, Decubitus Ulcer
Interventions: Not listed
Lead sponsor: Legacy Medical Consultants; Industry
Eligibility: 18 Years and older
Enrollment: 2,400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 4
States / cities: Colorado Springs, Colorado • Clinton Township, Michigan • Tulsa, Oklahoma + 1 more

Conditions: Diabetic Foot Ulcer
Interventions: Affinity human amniotic membrane; Other
Lead sponsor: Organogenesis; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 6
States / cities: Miami Lakes, Florida • North Miami Beach, Florida • Ford City, Pennsylvania + 3 more

Conditions: Foot Ulcer, Diabetic
Interventions: MatriStem, Cellular Dermal Replacement Tissue; Device
Lead sponsor: Integra LifeSciences Corporation; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 9
States / cities: Phoenix, Arizona • Castro Valley, California • Fresno, California + 5 more

Conditions: Foot Ulcer, Diabetic, Diabetes Complications
Interventions: MRE0094, Vehicle gel; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 19
States / cities: Phoenix, Arizona • Tucson, Arizona • Fresno, California + 16 more

Conditions: Venous Ulcer, Foot Ulcer, Diabetic
Interventions: Artacent Human Amniotic Membrane, Standard of Care; Other · Procedure
Lead sponsor: Tides Medical; Industry
Eligibility: 18 Years and older
Enrollment: 134 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 7
States / cities: Arcadia, California • New Iberia, Louisiana • New Orleans, Louisiana + 4 more

Conditions: Diabetic Foot Ulcer, Diabetic Foot
Interventions: Medaxis Debritom+, Sharp Surgical Debridement, Additional Outer Dressing Application, Offloading, Fibracol Wound Dressing; Other
Lead sponsor: Medaxis, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 222 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 6
States / cities: San Francisco, California • South Miami, Florida • Frederick, Maryland + 3 more

Conditions: Diabetic Foot Ulcers
Interventions: TruSkin®, Wound Cover; Other
Lead sponsor: Osiris Therapeutics; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 5
States / cities: Florida City, Florida • Illinois City, Illinois • Michigan, Michigan + 2 more

Conditions: Diabetic Foot Ulcers
Interventions: Epiflo, Moist Wound Therapy; Device · Other
Lead sponsor: Neogenix, LLC dba Ogenix; Industry
Eligibility: 20 Years to 90 Years
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 14
States / cities: Phoenix, Arizona • Tucson, Arizona • Encinitas, California + 11 more

Conditions: Wounds, Pressure Ulcer, Diabetic Foot Ulcer, Venous Leg Ulcer, Surgical Wound, Soft Tissue Reinforcement
Interventions: Kerecis Fish Skin Graft; Device
Lead sponsor: Kerecis Ltd.; Industry
Eligibility: Not listed
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 5
States / cities: Sarasota, Florida • Greensboro, North Carolina • Beavercreek, Ohio + 2 more

Conditions: Diabetic Foot Ulcer (DFU)
Interventions: Comprehensive Assistance and Resources for Effective Diabetic Foot Navigation; Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 4
States / cities: Atlanta, Georgia • Decatur, Georgia

Conditions: Diabetic Foot Ulcer, Diabetic Wound, Diabetes Mellitus, Type 2, Diabetic Foot, Diabetes Complications, Peripheral Neuropathy
Interventions: Peer counseling group; Behavioral
Lead sponsor: Casa Colina Hospital and Centers for Healthcare; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 3
States / cities: Downey, California • Los Angeles, California • Pomona, California

Conditions: Diabetic Foot Ulcers
Interventions: Moist Wound Therapy, VAC Therapy; Device
Lead sponsor: KCI USA, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 335 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2008
U.S. locations: 24
States / cities: Phoenix, Arizona • Tucson, Arizona • Castro Valley, California + 17 more

Conditions: Diabetic Foot Ulcer
Interventions: Orion TM Amniotic Membrane Allograft, Standard of Care (SOC); Device · Procedure
Lead sponsor: Legacy Medical Consultants; Industry
Eligibility: 50 Years to 85 Years
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 8
States / cities: Palm Springs, California • San Francisco, California • Vista, California + 5 more

Conditions: Foot Ulcer, Diabetic
Interventions: No intervention; Other
Lead sponsor: Podimetrics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 6,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Somerville, Massachusetts

Conditions: Determine Effectiveness of Theraskin in the Treatment of DFU and VLU
Interventions: Human Allograft (Theraskin); Other
Lead sponsor: Solsys Medical LLC; Industry
Eligibility: 18 Years and older
Enrollment: 188 participants
Timeline: 2003 – 2009
U.S. locations: 1
States / cities: Fairfax, Virginia

Conditions: Foot Ulcer, Diabetic
Interventions: PriMatrix; Device
Lead sponsor: Integra LifeSciences Corporation; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Diabetic Foot Ulcer, Amniotic Membrane Placental Allograft, Biologic
Interventions: Standard of Care, BIOxHEAL (human amniotic membrane allograft); Other · Biological
Lead sponsor: Applied Biologics, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 253 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Boardman, Ohio

Conditions: Diabetic Foot Ulcers
Interventions: DSC127, placebo vehicle gel; Drug
Lead sponsor: Integra LifeSciences Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 266 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 25
States / cities: Mobile, Alabama • Fair Oaks, California • Fresno, California + 22 more

Conditions: Diabetic Foot Ulcer
Interventions: Celliant Diabetic Medical Socks, Control (placebo) Medical Socks; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 22 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Diabetic Foot, Foot Ulcer, Diabetic
Interventions: Santyl, Product containing silver; Biological · Other
Lead sponsor: Smith & Nephew, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 11
States / cities: Sylmar, California • Melbourne, Florida • Baltimore, Maryland + 8 more

Conditions: Diabetic Foot Ulcer, Osteomyelitis Chronic
Interventions: Borate-base Bioactive Glass Fiber Matrix (BBGFM); Device
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Diabetic Foot Ulcer
Interventions: gentamicin-collagen sponge and levofloxacin, Levofloxacin only; Drug
Lead sponsor: Innocoll; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Lakeland, Florida

Conditions: Peripheral Arterial Disease, Diabetic Foot
Interventions: PDA-002, Placebo; Biological · Other
Lead sponsor: Celularity Incorporated; Industry
Eligibility: 18 Years and older
Enrollment: 159 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 45
States / cities: Birmingham, Alabama • Mesa, Arizona • Phoenix, Arizona + 37 more

Conditions: Diabetic Foot Infections
Interventions: 18F-FDG PET/CT; Diagnostic Test
Lead sponsor: Jewish General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Dallas, Texas

Search by objective public record fields.

Real-World Effectiveness of Amniotic Membrane Allografts Versus Standard Wound Care in DFU, VLU, and PU

Affinity Prospective Diabetic Foot Trial Crossover Group

A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers

Safety and Efficacy Study of MRE0094 to Treat Large, Single or Multiple, Chronic, Neuropathic, Diabetic Foot Ulcers

Efficacy and Safety of Artacent™ for Treatment Resistant Lower Extremity Venous and Diabetic Ulcers

A Unique Micro Water Jet Technology Device Versus Standard Debridement in the Treatment of Diabetic Foot

TruSkin®: Study for the Treatment of Chronic Diabetic Foot Ulcers

Transdermal Continuous Oxygen Therapy for Diabetic Foot Ulcers

Kerecis Real-World Fish Skin Graft Registry

CARE-D-FOOT-Nav Pilot

Peer Support for Patients With Diabetic Foot Ulcers

Randomized, Controlled Multicenter Trial of Vacuum Assisted Closure Therapy™ in Diabetic Foot Ulcers

Clinical Utility of an Amniotic Membrane Allograft for Diabetic Foot Ulcer Wound Management

Approaches to Foot Complication Prevention: A Survey of Diabetes Educators

Clinical Trial to Examine Effectiveness of a Human Allograft for Treatment of DFU and VLU

The Use of Bioscaffolds in Conjunction With Negative Pressure Therapy: A Prospective Randomized Double-Blinded Trial

a Prospective, Multicenter, Randomized Controlled Trial, With a Non-randomized Sentinel Cohort, Evaluating the Efficacy of Bioxheal, a Single-layer Placental-derived Biologic in Nonhealing Diabetic Foot Ulcers

Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers

Celliant Socks to Increase Tissue Oxygenation and Complete Wound Closure in Diabetic Foot Wounds

Use of Santyl in Diabetic Foot Ulcers

Mirragen Diabetic Foot Ulcer Study

The Safety and Efficacy of an Antibiotic Sponge in Diabetic Patients With Moderately Infected Foot Ulcers

Efficacy and Safety of Intramuscular PDA-002 in Subjects With Diabetic Foot Ulcer With and Without PAD.

18F-FDG PET/CT for Diagnosis of Diabetic Foot Osteomyelitis